1. Home
  2. MCB vs RGNX Comparison

MCB vs RGNX Comparison

Compare MCB & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Metropolitan Bank Holding Corp.

MCB

Metropolitan Bank Holding Corp.

HOLD

Current Price

$91.73

Market Cap

906.2M

Sector

Finance

ML Signal

HOLD

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$11.18

Market Cap

761.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCB
RGNX
Founded
1999
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
906.2M
761.9M
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
MCB
RGNX
Price
$91.73
$11.18
Analyst Decision
Buy
Strong Buy
Analyst Count
2
8
Target Price
$97.50
$30.38
AVG Volume (30 Days)
185.2K
1.0M
Earning Date
01-20-2026
03-12-2026
Dividend Yield
0.87%
N/A
EPS Growth
11.64
N/A
EPS
6.62
N/A
Revenue
$277,514,000.00
$161,318,000.00
Revenue This Year
$29.07
$133.58
Revenue Next Year
$7.96
$45.08
P/E Ratio
$13.90
N/A
Revenue Growth
2.53
91.30
52 Week Low
$47.08
$5.04
52 Week High
$96.75
$16.19

Technical Indicators

Market Signals
Indicator
MCB
RGNX
Relative Strength Index (RSI) 65.29 36.41
Support Level $87.74 $9.51
Resistance Level $96.75 $11.78
Average True Range (ATR) 3.62 1.07
MACD 0.70 -0.45
Stochastic Oscillator 74.08 25.30

Price Performance

Historical Comparison
MCB
RGNX

About MCB Metropolitan Bank Holding Corp.

Metropolitan Bank Holding Corp is a bank holding company. It provides a broad range of business, commercial, and retail banking products and services to small businesses, middle-market enterprises, public entities, and individuals in the New York metropolitan area. The services provided by the company include deposits, trade finance, cash management solutions, savings, electronic banking, cards, and others. The company also provides various lending products such as acquisition loans, construction loans, and lines of credit, for retail, office, hospitality, multifamily, mixed-use, warehouse and distribution, and specialty-use properties. The bank derives its revenue in the form of interest income on loans.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

Share on Social Networks: